Clinical Trial Update: A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of ZEN003694 in metastatic castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ZEN003694

Snippet

Sponsor: Zenith Epigenetics | Conditions: Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Status: COMPLETED